Physician profile
Michael A Lawless
NPI 1447934450
$2,713.35
in general payments reported to CMS, 2019-2025
13 companies · $1,196 in 2025
The $1,196 reported for 2025 was more than what 83% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $283 · 2024: $1,235 · 2025: $1,196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,713.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $617.07 | 2023-2025 | Propel, Nim Vital, Nim-Response |
| Integra Lifesciences Corporation | $558.98 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Hologic Sales and Service, LLC | $480.80 | 2024-2025 | Coolseal Generator |
| Inspire Medical Systems, INC. | $272.94 | 2023-2024 | Inspire |
| Acclarent, INC | $159.74 | 2024 | Acclarent Navwire |
| Aroa Biosurgery Incorporated | $138.62 | 2025 | |
| Acera Surgical, INC. | $126.61 | 2024 | Restrata Wound Matrix |
| Glaxosmithkline, LLC. | $121.10 | 2024 | Nucala |
| Ars Pharmaceuticals Operations, INC. | $115.43 | 2025 | Neffy |
| Genzyme Corporation | $34.94 | 2025 | |
| Cochlear Americas | $33.72 | 2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Regeneron Healthcare Solutions, INC. | $31.34 | 2024-2025 | Dupixent |
| Med-El Corporation | $22.06 | 2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lawless listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.